Ateme: EBITDA of €6.3m and net profit of €2.9m in first half
Ateme published its half-year results on September 10, 2026, approved the day before by its board of directors and whose limited review by statutory auditors is complete. The group indicates that it continued in the first half its reorganization and rationalization actions in order to contain the growth of operating expenses below revenue growth.
25% growth on a comparable basis, EBITDA margin at 12.5%
In the first half of 2026, Ateme's consolidated revenue increased by 25% on a comparable basis (at constant exchange rates and scope) and by 20% on a reported basis. Monthly recurring revenue (MRR) rose from €2.999m in January 2026 to €3.245m in July 2026, an increase of 8% over the half-year and 20% year-on-year. In July 2026, it represented an annual recurring revenue (ARR) of €38.9m. EBITDA stood at €6.3m, an increase of €4.8m compared to €1.5m in the first half of 2025. The group states that this is a record level for a first half. The EBITDA margin came in at 12.5%, compared to 3.7% in the first half of 2025.
Operating result of €3.6m and gross margin stable at 61%
Operating result improved by €4.7m to reach €3.6m, compared to an operating loss of €1.1m a year earlier. Net financial result was reduced to -€127k, compared to a loss of €2.2m in the first half of 2025, with foreign exchange gains practically offsetting interest charges on debt. After a tax charge of €0.6m, net result stood at €2.9m, compared to a net loss of €3.3m a year earlier, an improvement of €6.2m. The gross margin on direct costs stood at 75%, down 2 points compared to the first half of 2025 (77%) and stable compared to the 2025 fiscal year. Gross margin remained stable at 61%, with an increase of €5.6m in value (+22% year-on-year).
Net debt reduced to €16.1m and EBITDA target of €15m in 2026
Ateme generated operating cash flow of €9.0m over the half-year, supported in particular by the decrease in trade receivables. Available cash stood at €7.1m as of June 30, 2026, compared to €5.3m at end of 2025, while net financial debt amounted to €16.1m (of which €14.5m linked to CIR pre-financing), compared to €21.0m at end of 2025. The group recalls an established seasonality: in 2025, of €9.2m annual EBITDA, €1.5m was achieved in the first half and €7.7m in the second half. Given similar seasonality expected in 2026, Ateme targets EBITDA of €15m in 2026 and €22m in 2027, as well as an MRR of €4m by 2027. Next milestone, the publication of third quarter 2026 revenue is scheduled for October 22, 2026, after Euronext Paris market close.
